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The newly developed Illumina HumanMethylation450 BeadChip (450K array) (Illumina, 
Inc., San Diego, California) allows unprecedented genome-wide profiling of DNA methylation 
at >450,000 CpG and non-CpG methylation sites (Sandoval et al., 2011). Utilizing the 450K 
array, Philibert and colleagues examined the relationship of recent alcohol intake to genome-
wide methylation patterns in lymphoblast DNA samples derived from 165 female subjects 
participating in the Iowa Adoption Studies (Philibert et al., 2012). The authors’ interesting paper 
demonstrated that the 450K array could be a useful tool for ongoing and newly designed 
epigenome projects. However, given the unique design of the platform (for detailed annotations 
for the 450K array including probe sequences: http://www.illumina.com/), some cautions might 
need to be exerted when analyzing the 450K array data, in addition to some general challenges 
for analyzing the whole-genome DNA methylation data (Laird, 2010). Particularly, we found 
that a substantial proportion of the >450,000 DNA methylation probes on the 450K array are not 
aligned to unique, unambiguous loci in the human genome (Moen et al., 2012). In total, we 
found ~140,000 methylation probes ambiguously mapped to multiple locations in the human 
genome (hg19) with up to two mismatches in the probe sequences using Bowtie (v2.0.0 beta2) 
(Langmead et al., 2009;Langmead and Salzberg, 2012). Briefly, Bowtie is an ultrafast, memory-
efficient short read aligner by indexing the genome with an extended Burrows-Wheeler 
technique, which implements a novel quality-aware backtracking algorithm that permits 
mismatches (Langmead et al., 2009;Langmead and Salzberg, 2012). Different alignment 
algorithms, e.g., BLAT (Kent, 2002) and MAQ (Li et al., 2008), would provide similar estimates 
(unpublished data). In comparison, ~1,000 methylation probes were found to be ambiguously 
mapped to the human genome hg18 in the earlier 27K Illumina HumanMethylation array (27K 
array) (Bell et al., 2011). Because the much more comprehensive 450K array covers not only 
promoters, but also gene bodies, untranslated regions (UTRs) and “open sea” methylation sites, 
the problem of ambiguous alignment may particularly need to be taken into account when 
analyzing the data from this new platform. Notably, 20 CpG methylation probes (e.g., 
cg24023553 in Table II; cg00004209 in Table III; cg24675557 in Table V) (Philibert et al., 2012) 
out of the 90 top-ranking probes reported by Philibert et al. were mapped to ambiguous loci in 
the current human reference (hg19) using Bowtie (Langmead et al., 2009;Langmead and 
Salzberg, 2012). Since the problem of ambiguous alignment to the human genome may cause 
unreliable measurement of DNA methylation level at a particular methylation site, considering 
this unique problem for this platform may not only facilitate the data analysis (e.g., by improving 
the multiple-testing problem by removing those affected probes), but also help interpret the 
results by focusing on more reliable biological signals. In addition, other factors (e.g., 
polymorphisms in the target sequences, potential batch effects) that may affect other platforms 
(e.g., the 27K array) (Bell et al., 2011;Fraser et al., 2012) as well may also need to be considered 
in the analysis of these data. 
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